Abstract
Objective: The purpose of the study is to evaluate whether surgery followed by radiotherapy in high-risk patients of early stage endometrial cancer can be replaced by formal surgical staging. Cancer-related survival and recurrence-free survival (RFS) were the endpoints of the analysis. Study design: One hundred and eighteen patients with endometrioid endometrial adenocarcinoma between 1996–2003 were reviewed. Patients with incomplete follow-up and extrauterine spread excluded, leaving 78 women in the final analysis. Low-risk patients (n=37) (Grade 1, myometrial infiltration <1/2 or Grade2, <1/3), treated by standard surgical procedure including total abdominal hysterectomy, bilateral salpingo-oophorectomy and peritoneal washing, while staging lymphadenectomy (n=24) or postoperative irradiation (n=17) was added in the high-risk group (Grade 1, >1/2 or Grade 2, >1/3 or Grade3). Results: The median age of patients was 65 years (range, 35–80 years) and the median follow-up 38 months (range, 9–98 months). The recurrence rate in low-risk patients was 2.7%, the cancer-related survival 97.5% and RFS 97%, while in the high-risk patients 12%, 93% and 88%, respectively. Comparing the therapeutic modalities (staging lymphadenectomy vs. postoperative irradiation) in the high-risk group the cancer-related survival and RFS was not differed (P=0.70, P=0.90, respectively). The high grade of the tumor was significantly correlated with RFS, while age, stage and myometrial infiltration were not. No moderate or severe complications developed after lymphadenectomy, while two moderate gastrointestinal complications occurred after adjuvant radiotherapy. Conclusion: According our results the low-risk patients of early stage endometrial adenocarcinoma had excellent survival with minimal intervention. The cancer-related survival and RFS in high-risk patients concerning the therapeutic modalities were comparable. Poor tumor differentiation was the most unfavorable prognostic factor related with RFS. Moderate complications developed only after postoperative radiotherapy.
Similar content being viewed by others
References
Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427
Amant F, Moerman P, Neven P, Timmerman D, VanLimbergen E, Vergote I (2005) Endomatrial cancer. Lancet 366:491–505
Ayhan A, Taskiran C, Celik C et al (2002) Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage endometrial cancer? Gynecol Oncol 86:259–263
Ball HG (1996) Do we know the best therapy for the early stage endometrial cancer? Gynecol Oncol 60:173–175
Belinson JL, Lee KR, Badger GL, Pretorius RG, Jarre MA (1992) Clinical stage I adenocarcinoma of the endometrium, analysis of the reoccurrences and the potentional benefit of staging lymphadenectomy. Gynecol Oncol 44:17–23
Chassagne D, Sismondi P, Horiot JC et al (1993) A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26:183–202
COSA-NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Cancer 6:102–107
Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early stage endometrial cancer. J Clin Oncol 23:3653–3655
Creasman WT (1990) New gynecology cancer staging. Obstet Gynecol 75:287–288
Creasman WT, Morrow C, Bundy B, Homesley H, Graham J, Heller P (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecology Oncology Group study. Cancer 60:2035–2041
Creutzberg CL, Putten WLJ, Koper PCM et al for the PORTEC Study group (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial Carcinoma multicenter randomized trial. Lancet 355:1404–1411
DiSaia PJ, Creasman WT, Boronow RC, Blessing JA (1985) Risk factors and recurrence patterns in stage I endometrial cancer. Am J Obstet Gynecol 151:1009–1015
Gatta G, Lasota MB, Verfecchia A, the EUROCARE Working Group (1998) Survival of European women with gynaecological tumours during the period 1978–1989. Eur J Cancer 34:2218–2225
Goudge C, Bernhard S, Cloven NG, Morris P (2004) The impact of complete surgical staging on adjuvant treatment decision in endometrial cancer. Gynecol Oncol 93:536–539
Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992) Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 167:1225–1230
Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457–481
Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744–751
Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium. Survival comparison of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33
Kitchener HC, Redman CW, Swart AMC, Amos CL (2005) ASTEC (Surgery component) A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of the endometrial cancer (Abstract book). Int J Gynecol Cancer 15:77
Larson DM, Broste SK, Krawist BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91:355–359
Larson DM, Connor GP, Broste SK, Krawist BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398
Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TKH (2003) The value of pelvic and paraaortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13: 863–869
Mariani A, Sebo TJ, Katzmann JA et al (2005) Endometrial cancer: can nodal status be predicted with curettage. Gynecol Oncol 96:594–600
Mohan DS, Samuels MA, Selim MA et al (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70:165–171
Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777–788
Potish RA, Dusenbury KE (1990) Enteric of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Oncol Biol Phys 18:1005–1010
Sabbatini PJ, Kaled MA. Barakat R (2000) Endometrial cancer. Handbook of gynecologic oncology.2nd edn. Martin Dunitz Publisher, London pp 283–296
Shachar IB, Pavelka J, Cohn D et al (2005) Surgical staging for patients presenting with grade I endometrial carcinoma. Obstet Gynecol 105:487–493
Straughn JM Jr, Huh WK, Orr JW Jr et al (2003) Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295–300
Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343
Wolfson AH, Sightier SE, Markoe AM et al (1992) The prognostic significance of surgical staging for carcinoma of endometrium. Gynecol Oncol 45:142–146
Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic model to predict outcome for women with endometrial adenocarcinoma. Cancer 77:1115–1121
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papanikolaou, A., Kalogiannidis, I., Goutzioulis, M. et al. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Arch Gynecol Obstet 274, 91–96 (2006). https://doi.org/10.1007/s00404-006-0138-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-006-0138-y